Skip to main content
. Author manuscript; available in PMC: 2013 Jul 2.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Feb 28;38(1):4–15. doi: 10.1016/j.pnpbp.2012.02.009

Figure 3.

Figure 3

Concentration-response analysis with agonists illustrating full and partial agonists. Shown are a full agonist WIN 55,212-2 (■), a potent, partial agonist CP 55,940 (▲), and a less potent partial agonist anandamide (O). (Data adapted from McAllister et al, 1999).